Z Squared ZSQR
NASDAQ ZSQR
$3.95 +0.35 (+9.72%)
At close: Oct 22, 2026 · 4:00 PM EDT

Z Squared (ZSQR) Long-Term Debt Repayments (2022 - 2024)

Updated

Z Squared's Long-Term Debt Repayments was $63,469 in Q4 2024, down 81.9% from $350,001 a year earlier.

Analysis

Z Squared (ZSQR) Long-Term Debt Repayments (2022 - 2024) Analysis & Trends

For FY2024, Long-Term Debt Repayments at Z Squared came in at $650,969, down 46.9% from FY2023.

  • Long-Term Debt Repayments shows a four-year compound annual growth rate of 35.2% (FY2020 to FY2024).
  • In earlier years, Long-Term Debt Repayments was $1.23 million in FY2023 (-49.3%), $2.42 million in FY2022 (+42.2%), $1.7 million in FY2021 (+772.6%) and $194,830 in FY2020.
  • The Q4 2024 figure marks the lowest quarterly Long-Term Debt Repayments since Q3 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Repayment (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn 873.00 Mn
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn 1.00 Mn
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn 2.00 Bn
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn 5.00 Mn
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn 20.00 Mn
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn 2.46 Bn
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn -
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn 17.00 Mn
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn -
10 Z Squared 209.35 Mn 182.59 Mn -1.77 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 63,469.00
Mar 31, 2024 287,500.00
Dec 31, 2023 350,001.00
Sep 30, 2023 874,999.00
Dec 31, 2022 2.73 Mn
Sep 30, 2022 50,000.00
API Access

Z Squared Long-Term Debt Repayments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-repayments&ticker=ZSQR&period=max&api_key=YOUR_API_KEY